A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus

NCT01608412 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant Recipients

Interventions

DRUG: Tacrolimus
DRUG: Everolimus

Sponsor

Hospital de Clinicas de Porto Alegre